Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Other Non-Current Liabilities (2016 - 2025)

Cellectis has reported Other Non-Current Liabilities over the past 10 years, most recently at $1.3 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $1.3 million for Q4 2025, up 19.19% from a year ago — trailing twelve months through Dec 2025 was $1.3 million (up 19.19% YoY), and the annual figure for FY2025 was $1.3 million, up 19.19%.
  • Other Non-Current Liabilities for Q4 2025 was $1.3 million at Cellectis, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for CLLS hit a ceiling of $2.4 million in Q4 2022 and a floor of $626000.0 in Q4 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $1.3 million (2025), compared with a mean of $1.5 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 84.39% in 2021 and later surged 281.79% in 2022.
  • Cellectis' Other Non-Current Liabilities stood at $626000.0 in 2021, then surged by 281.79% to $2.4 million in 2022, then decreased by 7.95% to $2.2 million in 2023, then crashed by 49.32% to $1.1 million in 2024, then grew by 19.19% to $1.3 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $1.3 million (Q4 2025), $1.1 million (Q4 2024), and $2.2 million (Q4 2023) per Business Quant data.